Advertisement
Research Article

Antibody to Epstein-Barr Virus Deoxyuridine Triphosphate Nucleotidohydrolase and Deoxyribonucleotide Polymerase in a Chronic Fatigue Syndrome Subset

  • A. Martin Lerner mail,

    amartinlerner@yahoo.com

    Affiliation: Department of Medicine, Oakland University William Beaumont School of Medicine, Rochester, Michigan, United States of America

    X
  • Maria E. Ariza,

    Affiliation: Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, Ohio, United States of America

    X
  • Marshall Williams,

    Affiliation: Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, Ohio, United States of America

    X
  • Leonard Jason,

    Affiliation: Center for Community Research, DePaul University, Chicago, Illinois, United States of America

    X
  • Safedin Beqaj,

    Affiliation: Pathology Inc, Torrance, California, United States of America

    X
  • James T. Fitzgerald,

    Affiliation: Department of Medical Education, University of Michigan School of Medicine, Ann Arbor, Michigan, United States of America

    X
  • Stanley Lemeshow,

    Affiliation: College of Public Health, The Ohio State University, Columbus, Ohio, United States of America

    X
  • Ronald Glaser

    Affiliation: Institute for Behavioral Medicine Research, The Ohio State University, Columbus, Ohio, United States of America

    X
  • Published: November 14, 2012
  • DOI: 10.1371/journal.pone.0047891

Reader Comments (2)

Post a new comment on this article

Media Coverage of this Article

Posted by PLoS_ONE_Group on 17 Nov 2012 at 00:27 GMT

The following article represents some of the media coverage that has occurred for this paper:

Publication: Ohio State University
Title: “Discovery Could Lead to Faster Diagnosis For Some Chronic Fatigue Syndrome Cases”
http://researchnews.osu.e...

If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.

Competing interests declared: PLOS ONE Staff